CHRISTINE SCHRUNTEK: Open Payments
NPI 1083643324 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 56 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $652 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $374 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Alkermes, Inc. | 4 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, SPRAVATO, REXULTI, INGREZZA, WELLBUTRIN, LOREEV XR.
Industry payments across NJ — which companies pay providers there.
